Management of Delirium
Delirium management requires immediate identification and treatment of underlying medical causes while simultaneously implementing non-pharmacological interventions first, reserving antipsychotic medications for moderate to severe cases or when non-pharmacological approaches fail. 1
Immediate Assessment and Diagnosis
- Use the Confusion Assessment Method (CAM) or similar validated instruments to confirm delirium diagnosis, focusing on acute onset, fluctuating course, inattention, and altered consciousness 1
- Obtain history from knowledgeable informants to establish baseline cognitive function and timeline of changes, as this is the foundation of accurate diagnosis 1
- Perform repeated assessments throughout the day since cognitive status fluctuates substantially within hours, particularly in hypoactive delirium which carries higher mortality risk 1
- Recognize that delirium is a medical emergency with mortality twice as high if missed, requiring urgent intervention 1
Identify and Treat Underlying Causes
Obtain appropriate laboratory studies and imaging immediately to identify reversible causes including infection (especially urinary tract infections and pneumonia), toxic-metabolic disorders, electrolyte disturbances, hypoxia, organ failure, and medication effects 1
- Eliminate or reduce delirium-inducing medications, particularly steroids, anticholinergics, and benzodiazepines 1
- Evaluate for common precipitants: two or more coexisting causes are frequently present 1
- In cancer patients, assess for hypercalcemia, infection, and treatment-related neurotoxicity 2
- Consider opioid rotation if delirium appears related to opioid neurotoxicity 1
Non-Pharmacological Interventions (First-Line)
Maximize non-pharmacological interventions before using medications, as these are the cornerstone of delirium management 1, 3
- Implement frequent reorientation by staff and family members 1, 4
- Provide cognitive stimulation and maintain normal sleep-wake cycles with sleep hygiene measures 1
- Ensure adequate hydration, nutrition, and pain control 3
- Optimize the environment: reduce noise, provide adequate lighting during day, minimize nighttime disruptions 3, 4
- Provide 24-hour companion or sitter when possible for patient safety 5
- Remove unnecessary tubes, catheters, and monitoring devices 1
Pharmacological Management
Moderate Delirium
For moderate delirium symptoms, use oral antipsychotics as second-line treatment when non-pharmacological approaches are insufficient 1
- Olanzapine is recommended for moderate delirium (starting dose 5-10 mg daily, with additional 2.5 mg as needed) 1, 2, 6
- Quetiapine is an effective alternative for moderate symptoms 1, 2, 6
- Risperidone is also efficacious with fewer side effects than haloperidol 6
- Haloperidol remains an option but carries higher risk of extrapyramidal symptoms 1, 6
Severe Delirium with Agitation
For severe delirium with agitation, use antipsychotic neuroleptics such as haloperidol, olanzapine, or chlorpromazine 1, 2
- Titrate doses to optimal symptom relief, monitoring closely for response 1
- Use intravenous chlorpromazine only in bed-bound patients due to hypotensive effects 1
- Add benzodiazepines (lorazepam) only for agitation refractory to high-dose neuroleptics, not as initial treatment 1
- Benzodiazepines should be avoided as initial therapy except in alcohol or sedative-hypnotic withdrawal 1, 4
Special Considerations
Hypoactive Delirium
- Recognize that hypoactive delirium presents with cognitive slowing, motor retardation, and sedated appearance rather than agitation 1
- This subtype is more common in older adults and carries greater mortality risk, yet is frequently underdiagnosed 1
End-of-Life Delirium
- In dying patients with refractory delirium from disease progression, focus on symptom management and family support 1
- Increase neuroleptic and benzodiazepine doses and consider route changes to ensure adequate symptom control 1
- Consider palliative sedation for refractory terminal delirium after consultation with palliative care specialists 1
Monitoring and Follow-Up
- Measure delirium severity over time using validated scales to ensure appropriate response and resolution 1
- Continue treating underlying causes while managing symptoms 1, 3
- Provide ongoing education and support to caregivers throughout the episode, as delirium is highly distressing for families 1, 2
Critical Pitfalls to Avoid
- Never use benzodiazepines as first-line treatment except in alcohol or sedative withdrawal, as they can worsen delirium 1, 4
- Do not miss hypoactive delirium by only screening for agitated patients 1
- Avoid attributing symptoms to primary psychiatric disorders without ruling out medical causes first 1, 4
- Do not delay treatment while awaiting complete workup, as early intervention reduces mortality 1